Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection

OBJECTIVES: Treatment with pegylated interferon and ribavirin may prevent progression of liver disease among patients with chronic hepatitis C virus infection (HCV). Treatment initiation is based on published clinical eligibility criteria, patients’ willingness to undergo treatment and likelihood of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Livingston, Stephen E., Townshend-Bulson, Lisa J., Bruden, Dana L., McMahon, Brian J., Homan, Chriss E., Gove, James E., Deubner, Heike, Bruce, Michael G., Robinson, Renee F., Gretch, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: Co-Action Publishing 2012
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3417585/
https://ncbi.nlm.nih.gov/pubmed/22564468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ijch.v71i0.18445
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados